Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P51532 (
transcriptional activator
)
6,546
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have identified a novel human gene encoding a 59-kDa POZ-AT hook-zinc finger protein (PATZ) that interacts with
RNF4
, a mediator of androgen receptor activity, and acts as a transcriptional repressor. PATZ cDNA was isolated through a two-hybrid interaction screening using the RING finger protein
RNF4
as a bait. In vitro and in vivo interaction between
RNF4
and PATZ was demonstrated by protein-protein affinity chromatography and coimmunoprecipitation experiments. Such interaction occurred through a small region of PATZ containing an AT-hook DNA binding domain. Immunofluorescence staining and confocal microscopy showed that PATZ localizes in distinct punctate nuclear regions and colocalizes with
RNF4
. Functional analysis was performed by cotransfection assays: PATZ acted as a transcriptional repressor, whereas its partner
RNF4
behaved as a
transcriptional activator
. When both proteins were overexpressed a strong repression of the basal transcription was observed, indicating that the association of PATZ with
RNF4
switches activation to repression. In addition,
RNF4
was also found to associate with HMGI(Y), a chromatin-modeling factor containing AT-hook domains.
...
PMID:A novel member of the BTB/POZ family, PATZ, associates with the RNF4 RING finger protein and acts as a transcriptional repressor. 1071 5
PATZ is a transcriptional repressor affecting the basal activity of different promoters, whereas
RNF4
is a
transcriptional activator
. The association of PATZ with
RNF4
switches the activation to repression of selected basal promoters. Because
RNF4
interacts also with the androgen receptor (AR) functioning as a coactivator and, in turn,
RNF4
associates with PATZ, we investigated whether PATZ functions as an AR coregulator. We demonstrate that PATZ does not influence directly the AR response but acts as an AR corepressor in the presence of
RNF4
. Such repression is not dependent on histone deacetylases. A mutant
RNF4
that does not bind PATZ but enhances AR-dependent transcription is not influenced by PATZ, demonstrating that the repression by PATZ occurs only upon binding to
RNF4
. We also demonstrate that
RNF4
, AR, and PATZ belong to the same complex in vivo also in the presence of androgen, suggesting that repression is not mediated by the displacement of
RNF4
from AR. Finally, we show that the repression of endogenous PATZ expression by antisense expression plasmids in LNCaP cells results in a stronger androgen response. Our findings demonstrate that PATZ is a novel AR coregulator that acts by modulating the effect of a coactivator. This could represent a novel and more general mechanism to finely tune the androgen response.
...
PMID:PATZ attenuates the RNF4-mediated enhancement of androgen receptor-dependent transcription. 1171 14